Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data Validation
1.5 COVID-19 impact analysis at regional level
1.6 Data Sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Public sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Digital diabetes management industry 360° synopsis, 2018 – 2032 (USD Million)
2.2 Business trends
2.3 Regional trends
2.4 Product type trends
2.5 Patient type trends
2.6 End-use trends
Chapter 3 Digital Diabetes Management Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising number of people suffering from diabetes
3.2.1.2 Advent of artificial intelligence and big data analytics in diabetes devices
3.2.1.3 Rising healthcare expenditure towards diabetes
3.2.1.4 Growing awareness about technologically advanced products
3.2.1.5 Favorable reimbursement policies
3.2.1.6 Rising number of product launches
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of advanced devices
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By patient type
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.5.3 China
3.6 Reimbursement scenario
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Vendor matrix analysis, 2022
4.6 Competitive analysis of major market players
4.7 Competitive positioning matrix
4.8 Strategic outlook matrix
Chapter 5 Digital Diabetes Management Market Size and Forecast, By Product Type (USD Million)
5.1 Key trends, by product type
5.2 Devices
5.2.1 By device
5.2.1.1 Smart blood glucose meters
5.2.1.2 Smart CGM
5.2.1.3 Smart insulin pumps and patches
5.2.1.4 Smart insulin pens
5.2.2 By device type
5.2.2.1 Handheld
5.2.2.2 Wearable
5.3 Services
5.3.1 Software
5.3.2 Apps
Chapter 6 Digital Diabetes Management Market Size and Forecast, By Patient Type (USD Million)
6.1 Key trends, by patient type
6.2 Type 1
6.3 Type 2
Chapter 7 Digital Diabetes Management Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Home settings
7.4 Diagnostic centers & clinics
7.5 Others
Chapter 8 Digital Diabetes Management Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Medtronic Plc
9.3 F.Hoffmann-La Roche Ltd
9.4 Dexcom, Inc
9.5 Senseonics
9.6 Insulet Corporation
9.7 Tandem Diabetes Care, Inc
9.8 Ypsomed Holding
9.9 Ascensia Diabetes Care Holdings Ag
9.10 Tidepool
9.11 Glooko Inc
9.12 DarioHealth Corporation
9.13 Novo Nordisk A/S
9.14 Pendiq
9.15 Emperra GmbH E-Health Technologies
